COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome
暂无分享,去创建一个
J. Catineau | G. Chironi | F. Berthier | A. Pathak | F. Giammarile | Y. Claessens | I. Rouquette | V. Nataf | C. Dugourd | B. Dahmani | M. Faraggi | P. Brunner | F. Fuerxer | B. Serrano | F. Hugonnet | B. Paulmier | M. Dietz | O. Keita-Perse | M. Bouregba | I. Riss | M. Liberatore | N. Beau | C. Perrin | P. Sorlin | X. Magdelein | Ryan Lukas Farhad | C. S. B. I. P. V. A. C. M. N. N. X. F. S. J. M. C. S. Fissore-Magdelein Gabriel-Solean Dahmani Riss | C. Fissore-Magdelein | S. Gabriel-Solean | V. Dupasquier | M. Nicolai | N. Rijo | F. Olyve | S. Chaillou-Orpitz | J. Lepine | M. Lorillou | C. Maincent | S. Bertrand | C. Dittlot | G. Armando | P. Garcia | D. Tran
[1] Y. Hu,et al. [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[2] M. Kirienko,et al. FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[3] C. Roy,et al. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels , 2020, Radiology.
[4] T. Liang,et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study , 2020, BMJ.
[5] Jun Zhou,et al. Chest CT findings of COVID-19 pneumonia by duration of symptoms , 2020, European Journal of Radiology.
[6] S. Fanti,et al. COVID-19 pandemic: guidance for nuclear medicine departments , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[7] L. Camporota,et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? , 2020, Intensive Care Medicine.
[8] Annarita Ianniello,et al. 18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging , 2020, Journal of Thoracic Oncology.
[9] Yiyan Song,et al. Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 , 2020, Journal of medical virology.
[10] S. Xiao,et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies , 2020, Modern Pathology.
[11] Sijuan Zou,et al. FDG PET/CT of COVID-19 , 2020, Radiology.
[12] Chengcheng Yu,et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[13] P. Khong,et al. COVID-19 pneumonia: what has CT taught us? , 2020, The Lancet Infectious Diseases.
[14] Fang Liu,et al. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[15] Z. Fayad,et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection , 2020, Radiology.
[16] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[17] Sang Hyun Hwang,et al. Evaluation of Spleen Glucose Metabolism Using 18F-FDG PET/CT in Patients with Febrile Autoimmune Disease , 2017, The Journal of Nuclear Medicine.
[18] Philip J. Sayre,et al. Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge , 2015, EJNMMI Research.
[19] M. Tucci,et al. Assessment of lung inflammation with 18F-FDG PET during acute lung injury. , 2010, AJR. American journal of roentgenology.
[20] M. Mintun,et al. [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation. , 2009, American journal of respiratory and critical care medicine.
[21] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[22] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[23] Hisataka Kobayashi,et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] J. Vanoverschelde,et al. Glucose for the heart. , 1999, Circulation.
[25] B. Tribukait,et al. Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. , 1991, Experimental cell research.
[26] Runsheng Wang,et al. A Retrospective Observational Study , 2020 .
[27] G. Rossi,et al. Pulmonary sarcoidosis. , 2018, The Lancet. Respiratory medicine.
[28] R. Govindarajan,et al. Pulmonary sarcoidosis. , 1985, The Journal of the Association of Physicians of India.